Blog

[Le French Gut] – Biofortis is part of the national project Le French Gut, to accelerate the science of the microbiota

Biofortis as a unique full service CRO providing Nutrition Clinical Trials, Microbiome Investigation and Data Science for Human and Animal Health is part of Le French Gut project. Le French Gut project National contribution to collect 100,000 faecal samples and...

Biofortis continues its development alongside Institut Mérieux

Benoît Fouchaq, CEO of Biofortis SASAs part of a new strategy, Mérieux NutriSciences has decided to sell the majority of Biofortis’ shares to its Management, through a “Management Buy-Out” project. However, the Institut Mérieux, a major player in the service of public...

[PRESS RELEASE] Biofortis and ProDigest announce an agreement for a global collaboration in the field of Gastrointestinal Research

Ghent, Belgium and Saint-Herblain, France Oct. 23, 2020 – ProDigest, specialists in intestinal research and Biofortis, Mérieux NutriSciences’ Contract Research Organization serving innovation in nutrition, health, and microbiota studies, enter into a global...

Pharmabiotics 2020

Pharmabiotics 2020 March 10/11th Biofortis team will attend Pharmabiotics 2020 March 10-11th of March : focused on Microbiome Business, Sciences & Regulatory Affairs. During this event, Institut Merieux is pleased to deliver an award. The Pharmabiotics Young...

[EVENT] Biofortis, membre du comité d’organisation et Sponsor Silver de la Journée Nutrition & Microbiote 2025

16 octobre 2025, Nantes FRBiofortis participera à la Journée Nutrition & Microbiote, organisée par Atlanpôle Biothérapies, le 16 octobre 2025, en tant que membre du comité d’organisation, avec l’implication de Thomas Carton (Scientific Operations Manager), et...

[EVENT] – Biofortis and analyze & realize will be present at Vitafoods Europe 2025

May 20th/21st/22nd, 2025in Barcelona, SpainFor this 2025 edition, we will be present in the booth 3J136F on French Pavilion. Vitafoods Europe is one of the most important events in the world’s nutraceutical. Each year, the event gathers thousands of attendees and...

[ARTICLE] The intestinal microbiota, a major player in colorectal cancer

The colorectal cancer (CRC) ranks among the top 3 most frequent and deadly cancers in both men and women. Although the gut microbiota plays a pivotal role in maintaining intestinal homeostasis and overall health, recent research suggests its significant involvement in...

[PRESS RELEASE] Biofortis and Teranga strengthen their service offerings with the acquisition of NEOVIX group

A Strategic expansion to enhance services in Health & Wellness Nantes, France – March 4, 2025 – We are pleased to announce our strategic partnership with TERANGA Group. With the acquisition of NEOVIX Group (including AR2i, Cosmetic Office, White Tillet, SCM...

[ARTICLE] Diet supplementation with the probiotic Saccharomyces cerevisiae helps alleviate abdominal pain of IBS patients.

Jun 28, 2022 | Microbiome

IBS is a 3-letter acronym that strongly impacts the lives of millions of people worldwide. It stands for irritable...

[EVENT] Global Engage Microbiome & Probiotic R&D & Business Collaboration Forum: Europe

May 17, 2022 | News

May 24th and 25th, 2022We are pleased to meet you again during Global Engage - May 24th/25th in the Netherlands. Our...

[INFOGRAPHIC] Microbiome & Chocolate

Apr 19, 2022 | Microbiome

After a long Easter weekend filled with chocolate, it’s time to offer you an infographic on the impact of chocolate on...

AFCRO – EUCROF

Jan 16, 2020 | News

BIOFORTIS will be present at AFCRO - 9th day of Clinical Research - 30th of january We will be in force with certain representatives of our Clinical Operations, IT, business team ... Don’t hesitate...

Poster: Decrease diarrheal symptoms and modulation of intestinal microbiota by a new synbiotic in a murine model of food allergy

Jan 6, 2020 | Microbiome

This poster describes some of the microbiome analyses results obtained on a in vivo murine model of food allergy designed for the ProtAlSafe project. ProtAlSafe is a research collaborative project...

[POSTER] Fecal microbiota profile at diagnosis in the French IMODI cohort of breast cancer

Dec 11, 2019 | Microbiome, Pharma

Oumaïra Rahmouni (1), Cindy Pensec (1), Steven Roblin (1), Yao Amouzou (1), Amandine Charreton (2), Patricia Lapierre (3), Séverine Tabone-Eglinger (2), Isabelle Treilleux (2), Olivier Tredan (2),...

[Poster] A prospective observational study on breast cancer in Lyon and Dijon: description of the “breast cohort” of the IMODI project

Jul 12, 2019 | Microbiome

Oumaïra Rahmouni (1), Basile Frilley (1), Angélina Dion (1), Florence Gillaizeau (1), Amandine Charreton (2), Patricia Lapierre (3), Cindy Pensec (1), Manuel Desmars (1), Pierre-François Busson (1),...

Alzheimer’s & Brain Awareness Month: Could Alzheimer’s disease also be a gut disease?

Jun 28, 2019 | Health, Microbiome

In this month of Alzheimer's & Brain Awareness, we wanted to provide some scientific facts for how our gut microbiota might play a significant role in Alzheimer’s disease (AD). For more details...

Poster: Impact of Chemotherapy on the Intestinal Microbiome and Epithelial Barrier in PDX Models of Lung Cancer

May 3, 2019 | Microbiome

C. Pensec, A. Groh, D. Guenot, L. Calvet, Mignard, O. Duchamp, T. Carton, S. Leuillet, H. Blottiere, F. Le Vacon Along with 4 other partners, Biofortis Mérieux NutriSciences took part in the...